International Clinical Trial: Safety, Tolerability, and Efficacy of an Ultralow dose Estriol Eluting Vaginal Pessary (E-Leviate) compared to Standard Care in Patients with Pelvic Organ Prolapse and Genitourinary Syndrome of Menopause

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000695303) titled 'Safety, Tolerability, and Efficacy of an Ultralow dose Estriol Eluting Vaginal Pessary (E-Leviate) compared to Standard Care in Patients with Pelvic Organ Prolapse and Genitourinary Syndrome of Menopause' on June 11.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel

Primary Sponsor: Bespoke Clinical Research

Condition: Pelvic Organ Prolapse (POP) Genitourinary syndrome of menopause (GSM) Pelvic Organ Prolapse (POP) Genitourinary syndrome of menopause (GSM) Renal and Urogenital - Other renal and urogenit...